MK-8245

MK-8245 · Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MK-8245, covering 2014-06-12 to 2014-06-12. Get the full timeline:

Most recent: Clinical Trial Update: Pharmacokinetics and Pharmacodynamics of MK-8245 in Participants With Type 2 Diabetes (MK-8245-012) [Phase 1]